Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Buy
331,014
+40,000
+14% +$75.2K 0.79% 24
2026
Q1
$260K Hold
291,014
0.34% 52
2025
Q4
$294K Buy
+291,014
New +$361K 0.37% 55

Other funds holding IFRX

T3 Companies's IFRX Position: Q2 2026 in Review

T3 Companies increased its InflaRx (IFRX) stake by 14% in Q2 2026, buying an estimated $75.2K and bringing the position to 331,014 shares worth $741K. The position accounts for 0.79% of the portfolio, ranked #24.

T3 Companies first reported a position in IFRX in Q4 2025 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • T3 Companies held 331,014 shares of InflaRx worth $741K as of Q2 2026.
  • T3 Companies bought 40,000 InflaRx shares in Q2 2026, an estimated $75.2K.
  • InflaRx made up 0.79% of T3 Companies's portfolio in Q2 2026, its #24 holding.
  • T3 Companies first reported a position in InflaRx in Q4 2025 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.